Vericel (VCEL) Cost of Revenue (2011 - 2026)

Vericel's Cost of Revenue history runs 16 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 17.36% year-over-year to $19.2 million; the TTM figure through Mar 2026 stood at $73.5 million (up 12.18% YoY), while the FY2025 annual figure was $70.7 million, up 8.51% from the prior year.
• Cost of Revenue came in at $19.2 million for Q1 2026 at Vericel, down from $19.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $19.8 million in Q4 2025 to a low of $12.6 million in Q1 2022.
• A 5-year average of $16.0 million and a median of $16.1 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue gained 0.5% in 2024 and rose 17.36% in 2026, its largest moves.
• Vericel's Cost of Revenue stood at $14.4 million in 2022, then grew by 14.15% to $16.5 million in 2023, then gained by 2.35% to $16.9 million in 2024, then grew by 17.26% to $19.8 million in 2025, then dropped by 3.19% to $19.2 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $19.2 million, $19.8 million, and $17.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison